Cargando…
Personalising your health: an EU imperative
In the fast-moving world of personalised medicine there are many issues and barriers—not least when it comes to getting novel drugs and treatments swiftly to where they are really needed. Slow bench-to-bedside rates do not help the 500 million potential patients across the EU’s current 28 Member Sta...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533597/ https://www.ncbi.nlm.nih.gov/pubmed/28798813 http://dx.doi.org/10.3332/ecancer.2017.ed68 |